Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
EDSA
EDSA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
EDSA News
Biotech Stocks Surge Significantly
May 20 2026
NASDAQ.COM
Edesa to Present at 63rd European Renal Congress
May 19 2026
stocktwits
Edesa Biotech Shares Surge 54% Ahead of Key Presentation
Apr 28 2026
stocktwits
Edesa Biotech CEO to Present at ATS 2026 Respiratory Innovation Summit
Mar 31 2026
Newsfilter
Edesa Biotech Updates on Phase 2 Clinical Trial Progress
Mar 26 2026
Newsfilter
Box Inc Q4 Earnings Exceed Expectations
Mar 04 2026
Benzinga
Axon Reports Q4 Revenue and Earnings Beat Estimates
Feb 25 2026
Benzinga
Edesa Biotech's Drug Significantly Reduces Mortality Rates
Feb 24 2026
stocktwits
Edesa Biotech Reports Positive Clinical Data
Feb 24 2026
Newsfilter
EDESA BIOTECH INC - PARIDIPRUBART Demonstrates 30% Decrease in Pneumonia Mortality Rates
Feb 24 2026
moomoo
EDESA BIOTECH INC - PARIDIPRUBART LOWERS MORTALITY RATE TO 15% AMONG NON-IMV PATIENTS
Feb 24 2026
moomoo
Edesa Biotech Reports $2.2 Million Net Loss for Q1
Feb 13 2026
seekingalpha
EDESA BIOTECH REPORTS Q1 OPERATING EXPENSES OF USD 2.3 MILLION
Feb 13 2026
moomoo
Edesa Biotech Reports GAAP EPS of -$1.27, Exceeding Estimates by $0.51
Dec 14 2025
SeekingAlpha
Edesa Biotech Reveals Schedule for Upcoming Conferences
Oct 31 2025
Newsfilter
Edesa Biotech Announces Encouraging Phase 3 Outcomes for Paridiprubart in ARDS
Oct 28 2025
NASDAQ.COM
Show More News
